ClinicalTrials.gg
Sign In

Uveitis, Anterior clinical trials

The registry lists 56 studies for Uveitis, Anterior across more than 10 countries. 9 are recruiting or about to start. 38 of them are mainly about Uveitis, Anterior (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 2 narrower conditions too, such as Behcet Syndrome: 193 studies, 51 open.

Get an email when these change. Save the Uveitis, Anterior studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
33
Status unknown
7
Not yet recruiting
5
Recruiting
4
Active, not recruiting
3
Terminated
2

Phase

Phase 2
16
Phase 3
14
Phase 4
11
Phase 1
5

Where

United States
30
Germany
5
India
4
United Kingdom
4
China
3
Thailand
2

Who runs them

Clearside Biomedical, Inc. (4) · National Eye Institute (NEI) (3) · Eyegate Pharmaceuticals, Inc. (3) · University of California, San Francisco (2) · VivaVision Biotech, Inc (2) · Tarsier Pharma (2) · Alcon Research (2) · Sirion Therapeutics, Inc. (2)

What is being tested here

Drugs under test in Uveitis, Anterior studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ganciclovir102
Adalimumab102
Valganciclovir101
Upadacitinib101
Dexamethasone024
Difluprednate013
Adrenocorticotropic Hormone002
Triamcinolone Acetonide022
Triamcinolone022
Dexamethasone phosphate012

Drug classes tested here Corticosteroids 11

Coming up

1phase 3 study under way
3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Who these studies take

Of the 4 Uveitis, Anterior studies recruiting now, 2 (50%) set no upper age limit and 1 (25%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (50%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
102 (50%)2 (50%)
184 (100%)4 (100%)
304 (100%)4 (100%)
404 (100%)4 (100%)
504 (100%)4 (100%)
654 (100%)4 (100%)
754 (100%)4 (100%)
853 (75%)3 (75%)

Across all 56 studies, recruiting or not: 18% stop at 75 or younger and 9% at 65; 29% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 → or search them.